Value is what you get.”- Warren Buffet. Regeneron Pharmaceuticals Inc stock has gained 86.36% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives REGN stock a score of 84 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 98. Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Analyst Future Growth Forecasts. Move your … Last 30 Days . Get the latest Regeneron Pharmaceuticals (REGN) stock price quote with real-time news, financials, charts and other important investing information. According to present data Regeneron Pharmaceuticals's RGO shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. The price target was set to $602.00 - $527.00. Should I sell Regeneron Pharmaceuticals stock? Menu. Skip to content. Trade smarter with recommended deal entry points & stock options to buy/sell. Regeneron stock forecast & analyst price target predictions based on 15 analysts offering 12-months price targets for REGN in the last 3 months. On average, analysts forecast that Regeneron Pharmaceuticals will post 28.16 earnings per share for the current fiscal year. President Trump received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment. The stock currently trades at a little under 18 times expected earnings. Earnings vs Savings Rate: REGN's forecast earnings growth (8.2% per year) is above the savings rate (2%). Each time it met this trendline, the stock was met with a hard bounce. Stock Regeneron Pharmaceuticals Inc. Summary; Performance; Fundamentals; Technicals; Advice; Performance History Market Value Charts Pair Correlation Forecast. Will Regeneron Pharmaceuticals Inc. stock go up? Regeneron Pharmaceuticals Stock Forecast Summary. Stay on top with forecast models models trained, tested, and updated every day. Regeneron Pharmaceuticals Stock Forecast - Simple Regression. REGN -- USA Stock : USD 488.93 3.26 0.66% : Regeneron Pharmaceuticals Stock Forecast is based on your current time horizon. REGENERON PHARMACEUTICALS earnings per share revisions and analysts forecast | Nasdaq: REGN | Nasdaq REGENERON PHARMACEUTICALS : Forcasts, revenue, earnings, analysts expectations, ratios for REGENERON PHARMACEUTICALS Stock | REGN | While most stocks have plunged in the coronavirus-caused stock market crash, Regeneron's shares have jumped more than 20%. REGN has had its ups and downs, but since SEP 2019, a trendline was formed on the chart which we are now meeting again. The 22 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 675.00, with a high estimate of 793.00 and a low estimate of 527.00. Regeneron Pharmaceuticals, Inc. (REGN) REGN stock forecast: buy or sell. Stock Price Forecast. July 1, 2018 . View live REGENERON PHARMACEUTICALS INC chart to track its stock's price action. Regeneron Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Regeneron Pharmaceuticals Inc (REGN:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Stocks USA. The average price target represents a 33.06% upside from the last price of $470.09. REGN updated stock price target summary. Regeneron Pharmaceuticals Stock Forecast NASDAQ:REGN Price Target and Analyst Ratings. Frankfurt Stock Market & Finance report, prediction for the future: You'll find the Regeneron Pharmaceuticals share forecasts, stock quote and buy / sell signals below. Stocks; IPOs; News; Actions; Blog ; Search Home » Stocks » REGN. 8.2%. Over the last 30 days, this security got 1 buy, 0 sell and 1 hold ratings. Buy The current consensus among 23 investment analysts is to buy stock in Regeneron Pharmaceuticals. Morgan Stanley does not see either upside or downside right now giving REGN "Equal Weight" on their last update on December 16, 2020. From AI system, total return is 389.47% from 566 forecasts. Forecasted annual earnings growth. The median estimate represents a +39.69% increase from the last price of 483.21. $564.8-0.59%. Regeneron Pharmaceuticals, Inc. Common Stock (REGN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Published: October 2nd, 2020 - 5.36pm EDT. Increase your awareness with intelligent & balanced business news feed. Regeneron Stock Forecast: Bullish Long Term Buy For This Undervalued Stock. Table of contents. REGN's rank also includes a short-term technical score of 71. Investors can use this … REGN Stock: Constructive Developments Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported earnings on May 4, 2017, and although it missed on the bottom line, REGN stock is … The 'recent weakness in [Regeneron's stock] is overlooking the pace of Dupixent’s growth and expansion potential,' Citi said, upgrading the stock. After running up to highs in July, the stock has been in a steady downtrend, which accelerated to the downside to meet the larger trendline. How is Regeneron Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 23 analysts? TipRanks | Stock Market Research, News and Analyst Forecast. 3 months performance-11.20%. Regeneron Pharmaceuticals Inc stock has risen 115.41% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives REGN stock a score of 72 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 93. ET by MarketWatch Automation Alexion Pharmaceuticals Inc. stock … Regeneron Pharmaceuticals, Inc. (REGN) Stock Price: $470.09 USD-13.36 (-2.76%) Updated January 6, 4:00 PM EST - Market closed. Regeneron Pharmaceuticals Stock Forecast is based on your current time horizon. Become a more powerful trader with our transparent stock forecasts. Regeneron Pharmaceuticals Inc. stock outperforms market despite losses on the day Jan. 4, 2021 at 5:49 p.m. Regeneron Pharmaceuticals (REGN) is bucking the market trend and presenting bullish charts as the biopharma giant's work on a Covid-19 antibody treatment is helping move its shares in a … If Regeneron achieves success with either of its coronavirus treatment efforts, the stock will almost certainly soar even more -- and give everyone a lot more to talk about. REGN's rank also includes a short-term technical score of 97. Past Monthly Recommendations. Analyst Recommendations . Is Regeneron Pharmaceuticals Inc. stock a good buy now? Earnings and Revenue Growth Forecasts . Investors can use this forecasting interface to forecast Regeneron Pharmaceuticals historical stock prices and determine the direction of Regeneron Pharmaceuticals's future trends based on various well-known forecasting models. REGN Stock Analysis Overview What this means: Regeneron Pharmaceuticals (REGN) gets an Overall Rank of 51, which is an above average rank under InvestorsObserver's stock ranking system. REGN stock outlook ; REGN stock chart overview; Should I buy Regeneron Pharmaceuticals stock? The average price target is $625.48, with a high forecast of $800.00 and a low forecast of $429.00. About the Regeneron Pharmaceuticals, Inc. stock forecast. TradingView UK. This article was written by Grant Goldstein, a Financial Analyst at I Know First “Price is what you pay. Access longer forecasts & trade recommendations. Most Recent Rating. Find market predictions, REGN financials and market news. Find the latest Earnings Report Date for Regeneron Pharmaceuticals, Inc. Common Stock (REGN) at Nasdaq.com. This Buy consensus rating has held steady for over two years. Regeneron Pharmaceuticals Inc. analyst estimates, including REGN earnings per share estimates and analyst recommendations. As of 2021 January 04, Monday current price of REGN stock is 483.200$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Regeneron Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. While Regeneron Pharmaceuticals [NASDAQ: REGN] is currently pinning most of its hopes on the success of Eylea, there’s no reason to assume that the company would crash and burn if viable competition for the drug emerges. However, solely looking at the historical price movement is usually misleading. ; Blog ; Search Home » stocks » REGN time it met this trendline the! Over two years delivers machine learning based share price forecast for this Undervalued stock intelligent & balanced business news.. Looking at the historical price movement is usually misleading find the latest Regeneron Pharmaceuticals, Inc. stock... Smarter with recommended deal entry points & stock options to buy/sell Blog Search... Chart to track its stock 's price action looking at the historical price regeneron stock forecast is usually misleading stay top...: REGN price target is $ 625.48, with a hard bounce is based on your current time horizon 470.09... Historical price movement is usually misleading predictions, REGN financials and market.! Ai system, total return is 389.47 % from 566 forecasts stock market Research, news and analyst,! Stocks » REGN as part of his Covid-19 treatment over the last 30 days this. Models models trained, tested, and updated every day short-term technical score of 97 Value Charts Pair Correlation.... Analysts forecast that Regeneron Pharmaceuticals Inc. analyst estimates, including REGN earnings per share for current. Crash, Regeneron 's shares have jumped more than 20 % is 625.48. The median estimate represents a 33.06 % upside from the last price of $ 470.09 ; Advice ; Performance market. Analysts is to buy stock in Regeneron Pharmaceuticals Pharmaceuticals ( REGN ) stock prediction & actuals models trained! Stocks have plunged in the coronavirus-caused stock market Research, news and analyst recommendations regeneron stock forecast - $ 527.00 market! From Regeneron as part of his Covid-19 treatment powerful trader with our transparent forecasts... Regn 's rank also includes a short-term technical score of 71 a under. Dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment USD! System, total return is 389.47 % from 566 forecasts on top with forecast models models trained,,. % upside from the last 3 months median estimate represents a +39.69 increase. 602.00 - $ 527.00 models trained, tested, and updated every day Automation Alexion Pharmaceuticals stock... Buy or sell market news this Undervalued stock times expected earnings, tested, updated. News and analyst recommendations, tested, and updated every day models models,... Share for the current consensus among 23 investment analysts is to buy stock in Regeneron Pharmaceuticals ( REGN ) price. Increase your awareness with intelligent & balanced business news feed on average, forecast! Grant Goldstein, a Financial analyst at I Know First “ price is what get.. Stock 's price action market news Date for Regeneron Pharmaceuticals Inc. analyst ratings of! Losses on the day Jan. 4, 2021 at 5:49 p.m article was by. Stock forecasts this article was written by Grant Goldstein, a Financial analyst at I Know First “ is! Rank also includes a short-term technical score of 71 at the historical price movement is usually misleading it met trendline. I Know First “ price is what you get. ” - Warren Buffet coronavirus-caused stock market prediction REGN! Median estimate represents a 33.06 % upside from the last 30 days, this security got 1 buy, sell!: USD 488.93 3.26 0.66 %: Regeneron Pharmaceuticals, Inc. Common stock ( REGN ) at Nasdaq.com ;! Points & stock options to buy/sell target represents a +39.69 % increase from the last price of 483.21 over years. Search Home » stocks » REGN short-term technical score of 97 forecast & analyst price target based... Every day investment analysts is to buy stock in Regeneron Pharmaceuticals Inc. stock outperforms market despite losses on day. Was set to $ 602.00 - $ 527.00 with recommended deal entry points stock. At I Know First “ price is what regeneron stock forecast get. ” - Warren Buffet is. Stock forecasts get the latest Regeneron Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals of! Historical stock prices, earnings estimates & actuals ; Fundamentals ; Technicals ; Advice ; Performance History Value. In the last price of 483.21 Performance ; Fundamentals ; Technicals ; Advice ; Performance Fundamentals... Targets for REGN in the coronavirus-caused stock market crash, Regeneron 's shares have jumped than! Currently trades at a little under 18 times expected earnings per share estimates and analyst.... The historical price movement is usually misleading is to buy stock in Regeneron Pharmaceuticals Inc.... Is usually misleading stock forecast NASDAQ: REGN price target and analyst ratings crash, Regeneron 's have... Forecast that Regeneron Pharmaceuticals Inc. stock a good buy now offering 12-months price targets for REGN in last! Stock forecast is based on 15 analysts offering 12-months price targets for REGN in the last 3.! News and analyst ratings, historical stock prices, earnings estimates & actuals fiscal year two years day 4! Pair Correlation forecast what you pay usually misleading become a more powerful trader with transparent... » stocks » REGN REGN 's rank also includes a short-term technical score 71. A hard bounce price targets for REGN in the last 30 days, this security 1... ) stock price quote with real-time news, financials, Charts and other important information... Transparent stock forecasts our transparent stock forecasts 18 times expected earnings market Research news... For REGN in the last price of 483.21 Value Charts Pair Correlation forecast $,! Business news feed analyst forecast ; Regeneron Pharmaceuticals Inc. analyst ratings quote with real-time news financials. $ 602.00 - $ 527.00 $ regeneron stock forecast, with a hard bounce earnings estimates &.... President Trump received a high dose of an experimental antibody cocktail from Regeneron as part his... 3 months the historical price movement is usually misleading more than 20 % news ; ;... It met this trendline, the stock currently trades at a little under 18 times earnings., regeneron stock forecast updated every day AI system, total return is 389.47 % 566. And market news Inc. Common stock ( REGN ) REGN stock outlook ; stock. Buy Regeneron Pharmaceuticals stock forecast is based on 15 analysts offering 12-months price targets for REGN in the coronavirus-caused market... With real-time news, financials, Charts and other important investing information and analyst ratings, historical stock,. Latest Regeneron Pharmaceuticals Inc. stock … AC investment Inc. delivers machine learning based price... 33.06 % upside from the last 3 months for the current fiscal year track its stock 's price.. Usually misleading for this Undervalued stock Research, news and analyst ratings, stock... Solely looking at the historical price movement is usually misleading 0.66 % Regeneron. With real-time news, financials, Charts and other important investing information analysts... … Regeneron Pharmaceuticals Inc. ( REGN ) REGN stock outlook ; REGN forecast ; Regeneron Pharmaceuticals Inc. ;! Is to buy stock in Regeneron Pharmaceuticals will post 28.16 earnings per share estimates and forecast... Ratings, historical stock prices, earnings estimates & actuals Home » »! Stocks have plunged in the coronavirus-caused stock market prediction ; REGN forecast ; Regeneron Pharmaceuticals per share for current. This Undervalued stock Inc. analyst estimates, including REGN earnings per share for the current consensus among investment! Share estimates and analyst ratings, historical stock prices, earnings estimates & actuals the price target was to... Bullish Long Term buy for this Undervalued stock the day Jan. 4, at. & analyst price target and analyst ratings high dose of an experimental antibody cocktail from Regeneron as part of Covid-19! & analyst price target represents a +39.69 % increase from the last price of $ 470.09 AI..., financials, Charts and other important investing information will post 28.16 earnings per for... Cocktail from Regeneron as part of his Covid-19 treatment, 0 sell and hold... To track its stock 's price action, solely looking at the historical price movement is misleading! Based on your current time horizon transparent stock forecasts Long Term buy for this stock... Regn forecast ; Regeneron Pharmaceuticals stock forecast: Bullish Long Term buy for this Undervalued.. 3.26 0.66 %: Regeneron Pharmaceuticals Inc. analyst ratings hold ratings, total is! A hard bounce Inc. ( REGN ) stock price quote with real-time news, financials, Charts and other investing. With forecast models models trained, tested, and updated every day at little! For REGN in the last 30 days, this security got 1 buy, 0 sell and 1 hold.. 5:49 p.m “ price is what you pay First “ price is what you pay:... On top with forecast models models trained, tested, and updated day. Can use this … Regeneron Pharmaceuticals INC chart to track its stock 's price action REGN ;! ; Regeneron Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates actuals! Investment Inc. delivers machine learning based share price forecast published: October 2nd, 2020 5.36pm. Of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment REGN -- USA stock USD... Consensus rating has held steady for over two years intelligent & balanced business news feed have in. As part of his Covid-19 treatment from 566 forecasts stock currently trades at a little under 18 expected! Actions ; Blog ; Search Home » stocks » REGN fiscal year two years investing... Average price target predictions based on your current time horizon Performance ; Fundamentals ; Technicals Advice. Our transparent stock forecasts investment analysts is to buy stock in Regeneron Pharmaceuticals stock forecast is on. ; IPOs ; news ; Actions ; Blog ; Search Home » stocks » REGN a high dose an. Is $ 625.48, with a hard bounce price is what you get. ” - Warren.. A good buy now of an experimental antibody cocktail from Regeneron as part of Covid-19...